Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Top Up PhD Scholarships

Applications are open for the next round of our Top Up Scholarships for students who are undertaking their research in type 1 diabetes-related fields.

News & Events

Seed Funding Grants

Applications are open for the next round of our Seed Funding Grants for researchers dedicated to type 1 diabetes

News & Events

International Clinical Trials Day

To celebrate International Clinical Trials Day, we are highlighting a couple of a current trials underway at the Children's Diabetes Centre at the Kids Research Institute Australia and Perth Children's Hospital

News & Events

Professor Davis wins Diabetes Australia award

Professor Liz Davis, Head of Endocrinology and Diabetes at the Perth Children’s Hospital is one of three diabetes leaders to receive the Outstanding Achievement Award from Diabetes Australia.

News & Events

Wellbeing activities

We have put together some activities that you can do while you’re at home with your family. It’s important to talk to your family about how you are feeling, and we hope these activities will encourage those conversations while having a bit of fun.

News & Events

Medical Assessments

People with type 1 diabetes require the completion of a Medical Assessment form for activities such as driving, skipper tickets and scuba-diving etc.

Research

Lessons from 50 years of curing childhood leukaemia

One of the great success stories of modern medicine is undoubtedly the remarkable improvement in outcome for childhood cancer, achieved through the work of...

News & Events

The Kids Research Institute Australia welcomes world-leading new laws for vapes

The Kids Research Institute Australia welcomes the Federal Government's stringent vaping reforms that took effect on 1 July 2024.

Research

Start Stronger, Live Longer Resource Manual for Aboriginal Health Workers

This resource kit for Aboriginal health workers is an exciting milestone in the Rio Tinto Aboriginal Health partnership with The Kids Research Institute Australia

Research

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC

Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC.